{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:54:57Z","timestamp":1786121697387,"version":"build-2736575974"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014768","name":"Jiaxing University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014768","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82401428"],"award-info":[{"award-number":["82401428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003612"],"award-info":[{"award-number":["82003612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["JHSQY26H300005"],"award-info":[{"award-number":["JHSQY26H300005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bcp.2026.117853","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:08:29Z","timestamp":1772150909000},"page":"117853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The therapeutic potential of cytisine and its derivatives in disorders of the central nervous system"],"prefix":"10.1016","volume":"248","author":[{"given":"Ming","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiansi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117853_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fncel.2016.00225","article-title":"Editorial: CNS Recovery after Structural and \/ or Physiological \/ Psychological Damage","volume":"10","author":"Moftah","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/11587830-000000000-00000","article-title":"Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network","volume":"25","author":"Xu","year":"2011","journal-title":"CNS Drugs"},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.bcp.2026.117853_b0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.tips.2016.06.007","article-title":"Targeting Oxidative Stress in Central Nervous System Disorders","volume":"37","author":"Patel","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0025","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cell.2015.06.054","article-title":"Saturated Reconstruction of a Volume of Neocortex","volume":"162","author":"Kasthuri","year":"2015","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bcp.2026.117853_b0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0035","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/cells10020370","article-title":"Endogenous Mechanisms of Neuroprotection: To Boost or Not to Boost","volume":"10","author":"Marmolejo-Mart\u00ednez-Artesero","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.117853_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107190","article-title":"Expression and function of nicotinic acetylcholine receptors in specific neuronal populations: Focus on striatal and prefrontal circuits","volume":"204","author":"Abbondanza","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117853_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","article-title":"Nicotinic acetylcholine receptors: from structure to brain function","volume":"147","author":"Hogg","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tips.2004.04.006","article-title":"Nicotinic acetylcholine receptors and the regulation of neuronal signalling","volume":"25","author":"Dajas-Bailador","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"issue":"6921","key":"10.1016\/j.bcp.2026.117853_b0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature01339","article-title":"Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation","volume":"421","author":"Wang","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bcp.2015.07.032","article-title":"Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection","volume":"97","author":"Egea","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117853_b0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1385\/JMN:30:1:181","article-title":"CNS localization of neuronal nicotinic receptors","volume":"30","author":"Nashmi","year":"2006","journal-title":"J. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2026.117853_b0075","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/membranes11090664","article-title":"Homomeric and Heteromeric \u03b17 Nicotinic Acetylcholine Receptors in Health and Some Central Nervous System Diseases","volume":"11","author":"Borroni","year":"2021","journal-title":"Membranes (basel)"},{"key":"10.1016\/j.bcp.2026.117853_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cophys.2017.12.012","article-title":"A tale of ligands big and small: an update on how pentameric ligand-gated ion channels interact with agonists and proteins","volume":"2","author":"Pless","year":"2019","journal-title":"Curr. Opin. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0085","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tips.2009.12.005","article-title":"Binding, activation and modulation of Cys-loop receptors","volume":"31","author":"Miller","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0090","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.cell.2021.02.049","article-title":"Structure and gating mechanism of the \u03b17 nicotinic acetylcholine receptor","volume":"184","author":"Noviello","year":"2021","journal-title":"Cell"},{"issue":"7625","key":"10.1016\/j.bcp.2026.117853_b0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nature19785","article-title":"X-ray structure of the human \u03b14\u03b22 nicotinic receptor","volume":"538","author":"Morales-Perez","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0033583510000168","article-title":"The structural basis of function in Cys-loop receptors","volume":"43","author":"Thompson","year":"2010","journal-title":"Q. Rev. Biophys."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0105","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuron.2016.03.032","article-title":"Emerging Molecular Mechanisms of Signal Transduction in Pentameric Ligand-Gated Ion Channels","volume":"90","author":"Nemecz","year":"2016","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0110","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.str.2019.04.008","article-title":"Identification of the Initial Steps in Signal Transduction in the \u03b14\u03b22 Nicotinic Receptor: Insights from Equilibrium and Nonequilibrium Simulations","volume":"27","author":"Oliveira","year":"2019","journal-title":"Structure"},{"issue":"30","key":"10.1016\/j.bcp.2026.117853_b0115","doi-asserted-by":"crossref","first-page":"21558","DOI":"10.1074\/jbc.M113.481689","article-title":"The minimum M3-M4 loop length of neurotransmitter-activated pentameric receptors is critical for the structural integrity of cytoplasmic portals","volume":"288","author":"Baptista-Hon","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031270","article-title":"Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators","volume":"28","author":"Manetti","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0306-4522(01)00538-3","article-title":"Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory","volume":"109","author":"Levin","year":"2002","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0130","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1523\/JNEUROSCI.18-06-01963.1998","article-title":"Glutamate and GABA release are enhanced by different subtypes of presynaptic nicotinic receptors in the lateral geniculate nucleus","volume":"18","author":"Guo","year":"1998","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0135","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.70061","article-title":"Therapeutic Targeting of the \u03b17 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia","volume":"137","author":"Magnussen","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0140","first-page":"161","article-title":"Vorl\u00e4ufige Mittheilung \u00fcber Cytisin und Laburnin, zwei neue Pflanzenbasen in Cytisus laburnum, Zeitschrift f\u00fcr","volume":"8","author":"M.W. Husemann A,","year":"1985","journal-title":"Chemie"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0145","first-page":"777","article-title":"Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy","volume":"58","author":"Tutka","year":"2006","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2026.117853_b0150","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1525\/aa.1962.64.5.02a00040","article-title":"The Origins of Plains Mescalism","volume":"64","author":"Troike","year":"1962","journal-title":"Am. Anthropol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117853_b0155","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/ps.1622","article-title":"Actions of quinolizidine alkaloids on Periplaneta americana nicotinic acetylcholine receptors","volume":"64","author":"Liu","year":"2008","journal-title":"Pest Manag. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0160","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12677\/HJMCe.2018.64013","article-title":"Research progress in pharmacological effects of cytisine (in Chinese)","volume":"6","author":"Ji","year":"2018","journal-title":"Hans Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0165","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/tc.2006.016097","article-title":"An uncontrolled trial of cytisine (Tabex) for smoking cessation","volume":"15","author":"Zatonski","year":"2006","journal-title":"Tob. Control"},{"key":"10.1016\/j.bcp.2026.117853_b0170","article-title":"Cytisine and cytisine derivatives","volume":"170","author":"Gotti","year":"2021","journal-title":"More than Smoking Cessation Aids, Pharmacol Res"},{"key":"10.1016\/j.bcp.2026.117853_b0175","unstructured":"I. Achieve Life Sciences, Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation, Achieve Life Sciences, Inc., Seattle, WA, 2025."},{"issue":"10","key":"10.1016\/j.bcp.2026.117853_b0180","first-page":"2679","article-title":"Research progress on chemical structures and pharmacological activities of natural cytisine and its derivatives(in Chinese)","volume":"48","author":"Zhou","year":"2023","journal-title":"China Journal of Chinese Materia Medica"},{"key":"10.1016\/j.bcp.2026.117853_b0185","year":"2020"},{"key":"10.1016\/j.bcp.2026.117853_b0190","series-title":"United States Pharmacopeial","author":"C.","year":"2022"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2026.117853_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2009.01.011","article-title":"Fatal cytisine intoxication and analysis of biological samples with LC-MS\/MS","volume":"186","author":"Musshoff","year":"2009","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.bcp.2026.117853_b0200","unstructured":"Food, A. Drug, Cytisine GPO 1.5 mg tablet: Package leaflet and Summary of Product Characteristics (SmPC), Ministry of Public Health, Food and Drug Administration (Thailand)."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0205","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s13256-024-04938-w","article-title":"An example of cytisine overdose with no consequent side-effects: a case report","volume":"18","author":"Campagnari","year":"2024","journal-title":"J. Med. Case Rep."},{"issue":"5","key":"10.1016\/j.bcp.2026.117853_b0210","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1471-4159.2001.00481.x","article-title":"Activity of cytisine and its brominated isosteres on recombinant human alpha7, alpha4beta2 and alpha4beta4 nicotinic acetylcholine receptors","volume":"78","author":"Houlihan","year":"2001","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.str.2012.05.003","article-title":"Structure and pharmacology of pentameric receptor channels: from bacteria to brain","volume":"20","author":"Corringer","year":"2012","journal-title":"Structure"},{"issue":"7237","key":"10.1016\/j.bcp.2026.117853_b0220","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature07768","article-title":"Nicotine binding to brain receptors requires a strong cation-pi interaction","volume":"458","author":"Xiu","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1566-0702(01)00386-1","article-title":"Nicotinic acetylcholine receptors in autonomic ganglia","volume":"97","author":"Skok","year":"2002","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.bcp.2026.117853_b0230","article-title":"The Structure","volume":"13","author":"Cetin","year":"2020","journal-title":"Function, and Physiology of the Fetal and Adult Acetylcholine Receptor in Muscle, Front Mol Neurosci"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0235","doi-asserted-by":"crossref","first-page":"130a","DOI":"10.1016\/j.bpj.2009.12.706","article-title":"Photoaffinity Labeling the Agonist Binding Sites of Torpedo and \u03b14\u03b22 Nicotinic Acetylcholine Receptors and Acetylcholine Binding Proteins (AChBPs) with [3H]Cytisine","volume":"98","author":"Srivastava","year":"2010","journal-title":"Biophys. J ."},{"key":"10.1016\/j.bcp.2026.117853_b0240","doi-asserted-by":"crossref","unstructured":"R. West, W. Zatonski, M. Cedzynska, D. Lewandowska, J. Pazik, P. Aveyard, J. Stapleton, Placebo-Controlled Trial of Cytisine for Smoking Cessation, New England Journal of Medicine 365(13) 1193-1200.","DOI":"10.1056\/NEJMoa1102035"},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0245","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/jama.2023.10042","article-title":"Cytisinicline for Smoking Cessation: A Randomized Clinical Trial","volume":"330","author":"Rigotti","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0026-895X(25)09896-7","article-title":"Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit","volume":"45","author":"Papke","year":"1994","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117853_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079653","article-title":"Acute activation, desensitization and smoldering activation of human acetylcholine receptors","volume":"8","author":"Campling","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.117853_b0260","series-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection","first-page":"59","article-title":"Nicotinic Acetylcholine Receptor Signaling: Roles in Neuroprotection","author":"Kume","year":"2018"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2026.117853_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.02.012","article-title":"C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists","volume":"536","author":"Abin-Carriquiry","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0270","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.chempr.2018.05.007","article-title":"Unlocking Nicotinic Selectivity via Direct C‒ H Functionalization of (\u2212)-Cytisine","volume":"4","author":"Rego Campello","year":"2018","journal-title":"Chem"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0275","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/aps.2009.51","article-title":"Allosteric activation mechanism of the cys-loop receptors","volume":"30","author":"Chang","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"10","key":"10.1016\/j.bcp.2026.117853_b0280","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1074\/jbc.M112.439968","article-title":"Binding interactions with the complementary subunit of nicotinic receptors","volume":"288","author":"Blum","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijdr.IJDR_711_18","article-title":"Effects of smoking on oral health: Awareness among dental patients and their attitude towards its cessation","volume":"32","author":"More","year":"2021","journal-title":"Indian J. Dent. Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.117853_b0290","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2013.06.019","article-title":"Smoking is bad for lungs, right?","volume":"32","author":"Shah","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0295","first-page":"301","article-title":"Cigarette smoking and cardiovascular risk in young women with polycystic ovary syndrome","volume":"7","author":"Morotti","year":"2014","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.bcp.2026.117853_b0300","series-title":"WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke","author":"O. World Health","year":"2023"},{"key":"10.1016\/j.bcp.2026.117853_b0305","series-title":"College of, Nicotine without smoke: Tobacco harm reduction","author":"Royal","year":"2016"},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0310","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/08870446.2017.1325890","article-title":"Tobacco smoking: Health impact, prevalence, correlates and interventions","volume":"32","author":"West","year":"2017","journal-title":"Psychol. Health"},{"key":"10.1016\/j.bcp.2026.117853_b0315","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ypmed.2018.06.010","article-title":"Managing nicotine without smoke to save lives now: Evidence for harm minimization","volume":"117","author":"Abrams","year":"2018","journal-title":"Prev. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0320","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acsomega.6b00489","article-title":"Aldehyde Detection in Electronic Cigarette Aerosols","volume":"2","author":"Ogunwale","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.bcp.2026.117853_b0325","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000146.pub5","article-title":"Nicotine replacement therapy versus control for smoking cessation","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database of Systematic Reviews (5)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2026.117853_b0335","unstructured":"M. Fiore, Treating Tobacco Use and Dependence: 2008 Update: Clinical Practice Guideline, in: U. United States. Tobacco, P. Dependence Guideline, C. Centers for Disease, Prevention (Eds.) U.S. Dept. of Health and Human Services, Public Health Service, United States, 2008."},{"issue":"01","key":"10.1016\/j.bcp.2026.117853_b0340","first-page":"74","article-title":"Research Progress on the Association between Gene Polymorphisms Related to the Dopamine System Pathway and Smoking Behavior(in Chinese)","volume":"41","author":"Chi","year":"2025","journal-title":"Journal of Clinical Cardiology"},{"key":"10.1016\/j.bcp.2026.117853_b0345","first-page":"11","article-title":"The neurotransmitter basis of tobacco and nicotine addiction(in Chinese)","author":"Luo","year":"2008","journal-title":"Chinese Journal of Drug Dependence (02)"},{"issue":"10","key":"10.1016\/j.bcp.2026.117853_b0350","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.18777","article-title":"Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation","volume":"3","author":"Liu","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0355","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/npp.2011.322","article-title":"AT-1001: a high affinity and selective \u03b13\u03b24 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats","volume":"37","author":"Toll","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101455","article-title":"Assessing potentiation of the (\u03b14)3(\u03b22)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI","volume":"298","author":"Deba","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(02)03733-2","article-title":"Cytisine binds with similar affinity to nicotinic alpha4beta2 receptors on the cell surface and in homogenates","volume":"959","author":"Zhang","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2026.117853_b0370","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pbb.2013.07.012","article-title":"The effects of noncontingent and self-administered cytisine on body weight and meal patterns in male Sprague-Dawley rats","volume":"110","author":"Grebenstein","year":"2013","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0375","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00213-013-3043-7","article-title":"The effects of extended intravenous nicotine administration on body weight and meal patterns in male Sprague-Dawley rats","volume":"228","author":"Grebenstein","year":"2013","journal-title":"Psychopharmacology"},{"issue":"25","key":"10.1016\/j.bcp.2026.117853_b0380","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMoa1407764","article-title":"Cytisine versus nicotine for smoking cessation","volume":"371","author":"Walker","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0385","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamainternmed.2025.0628","article-title":"Cytisinicline for Smoking Cessation: The ORCA Phase 3 Replication Randomized Clinical Trial","volume":"185","author":"Rigotti","year":"2025","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bcp.2026.117853_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110936","article-title":"Cytisine for smoking cessation: A systematic review and meta-analysis","volume":"251","author":"Ofori","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bcp.2026.117853_b0395","article-title":"Research progress in biological activity of Cytisine(in Chinese)","author":"Zhang","year":"2020","journal-title":"Modern Animal Husbandry Science & Technology (03)"},{"key":"10.1016\/j.bcp.2026.117853_b0400","series-title":"New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin","author":"Caraci","year":"2020"},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0405","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells10061309","article-title":"Neuroprotective Natural Products for Alzheimer's Disease","volume":"10","author":"Chen","year":"2021","journal-title":"Cells"},{"issue":"10284","key":"10.1016\/j.bcp.2026.117853_b0410","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0415","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2026.117853_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106743","article-title":"Discoveries and future significance of research into amyloid-beta\/\u03b17-containing nicotinic acetylcholine receptor (nAChR) interactions","volume":"191","author":"Whiteaker","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0425","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00259-020-05029-w","article-title":"(+)-[(18)F]Flubatine as a novel \u03b14\u03b22 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with \u03b2-amyloid PET-confirmed Alzheimer's disease and healthy controls","volume":"48","author":"Tiepolt","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0430","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jnnp.2006.108209","article-title":"Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography","volume":"78","author":"O'Brien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0435","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00259-010-1644-5","article-title":"Decreased cerebral \u03b14\u03b22* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography","volume":"38","author":"Kendziorra","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0440","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0006-3223(00)01116-1","article-title":"Nicotinic receptor abnormalities in Alzheimer's disease","volume":"49","author":"Court","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0445","article-title":"Neuronal and Glial \u03b17 Nicotinic Acetylcholine Receptors: Role in Alzheimer's Disease Pathophysiology","volume":"15","author":"Rennie","year":"2025","journal-title":"Life (basel)"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0450","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1046\/j.1471-4159.2000.0751155.x","article-title":"Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors","volume":"75","author":"Wang","year":"2000","journal-title":"J. Neurochem."},{"issue":"18","key":"10.1016\/j.bcp.2026.117853_b0455","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1111\/bph.14688","article-title":"Quantitative assessment of oligomeric amyloid \u03b2 peptide binding to \u03b17 nicotinic receptor","volume":"176","author":"Cecon","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"34","key":"10.1016\/j.bcp.2026.117853_b0460","doi-asserted-by":"crossref","first-page":"31547","DOI":"10.1074\/jbc.M212532200","article-title":"Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0465","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0306-4522(01)00460-2","article-title":"Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease","volume":"110","author":"Nagele","year":"2002","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.bcp.2026.117853_b0470","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1460-9568.2010.07116.x","article-title":"beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: involvement of lipid rafts","volume":"31","author":"Khan","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0475","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0480","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bcp.2011.06.039","article-title":"Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease","volume":"82","author":"Parri","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117853_b0485","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuro.2012.09.009","article-title":"Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors","volume":"34","author":"Li","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bcp.2026.117853_b0490","series-title":"Nicotinic Acetylcholine Receptor Signaling in Neuroprotection","first-page":"173","article-title":"Removal of Blood Amyloid As a Therapeutic Strategy for Alzheimer\u2019s Disease: The Influence of Smoking and Nicotine","author":"Kitaguchi","year":"2018"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0495","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3233\/JAD-2012-121447","article-title":"Modulation of \u03b17 nicotinic acetylcholine receptor and fibrillar amyloid-\u03b2 interactions in Alzheimer's disease brain","volume":"33","author":"Ni","year":"2013","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0500","first-page":"5626","article-title":"beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity","volume":"275","author":"Wang","year":"2000","journal-title":"Implications for Alzheimer's Disease Pathology, J Biol Chem"},{"issue":"7","key":"10.1016\/j.bcp.2026.117853_b0505","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","article-title":"Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation","volume":"28","author":"Rollema","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0510","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0006-8993(98)00138-3","article-title":"Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity","volume":"792","author":"Kihara","year":"1998","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0515","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3233\/JAD-180945","article-title":"17 Oxo Sparteine and Lupanine, Obtained from Cytisus scoparius, Exert a Neuroprotection against Soluble Oligomers of Amyloid-\u03b2 Toxicity by Nicotinic Acetylcholine Receptors","volume":"67","author":"Gavilan","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bcp.2026.117853_b0520","article-title":"Cytisine N-methylene-(5,7,4\u2019-trihydroxy)-isoflavone induces neural stem cell proliferation and reverses cognitive deficits in early Alzheimer's disease models via canonical Wnt\/\u03b2-catenin pathway","volume":"14","author":"Lu","year":"2024","journal-title":"Food Sci. Human Wellness"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0525","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12017-013-8242-1","article-title":"Nicotine prevents synaptic impairment induced by amyloid-\u03b2 oligomers through \u03b17-nicotinic acetylcholine receptor activation","volume":"15","author":"Inestrosa","year":"2013","journal-title":"Neuromolecular Med."},{"issue":"20","key":"10.1016\/j.bcp.2026.117853_b0530","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1523\/JNEUROSCI.3934-06.2007","article-title":"Wnt-7a induces presynaptic colocalization of alpha 7-nicotinic acetylcholine receptors and adenomatous polyposis coli in hippocampal neurons","volume":"27","author":"Far\u00edas","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2026.117853_b0535","unstructured":"A. Kouli, K.M. Torsney, W.L. Kuan, Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis, in: T.B. Stoker, J.C. Greenland (Eds.), Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects, Codon Publications, Brisbane (AU), 2018, p. Chapter 1."},{"key":"10.1016\/j.bcp.2026.117853_b0540","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000542606","article-title":"Disease Burden of Parkinson\u2019s Disease in Asia and Its 34 Countries and Territories from 1990 to 2021: Findings from the Global Burden of Disease Study 2021","author":"Yang","year":"2024","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27082484","article-title":"Beneficial Effects of Capsaicin in Disorders of the Central Nervous System","volume":"27","author":"Pasierski","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0550","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12993-025-00279-w","article-title":"Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death","volume":"21","author":"\u00c1lvarez-Luqu\u00edn","year":"2025","journal-title":"Behav. Brain Funct."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0555","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.077792","article-title":"Pharmacological chaperoning of nicotinic acetylcholine receptors reduces the endoplasmic reticulum stress response","volume":"81","author":"Srinivasan","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2026.117853_b0560","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1124\/mol.110.067561","article-title":"\u03b16\u00df2* and \u03b14\u00df2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease","volume":"78","author":"Perez","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"20","key":"10.1016\/j.bcp.2026.117853_b0565","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.3390\/molecules26206139","article-title":"Neuroinflammation Modulation via \u03b17 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3","volume":"26","author":"Mizrachi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2026.117853_b0570","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuro.2017.01.002","article-title":"Nicotine suppresses the neurotoxicity by MPP(+)\/MPTP through activating \u03b17nAChR\/PI3K\/Trx-1 and suppressing ER stress","volume":"59","author":"Cai","year":"2017","journal-title":"Neurotoxicology"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0575","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mds.25817","article-title":"ABT-089 and ABT-894 reduce levodopa-induced dyskinesias in a monkey model of Parkinson's disease","volume":"29","author":"Zhang","year":"2014","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.bcp.2026.117853_b0580","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/toxins11120682","article-title":"Qualitative Assay to Detect Dopamine Release by Ligand Action on Nicotinic Acetylcholine Receptors","volume":"11","author":"Marquart","year":"2019","journal-title":"Toxins (basel)"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0585","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2008.05.013","article-title":"In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: Implications for Parkinson's Disease","volume":"589","author":"Abin-Carriquiry","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.bcp.2026.117853_b0590","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(98)00696-7","article-title":"Effects of cytisine on hydroxyl radicals in vitro and MPTP-induced dopamine depletion in vivo","volume":"360","author":"Ferger","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0595","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0600","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41531-024-00855-3","article-title":"Systemically circulating 17\u03b2-estradiol enhances the neuroprotective effect of the smoking cessation drug cytisine in female parkinsonian mice","volume":"11","author":"Zarate","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"issue":"Pt B","key":"10.1016\/j.bcp.2026.117853_b0605","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2015.01.022","article-title":"Inside-out neuropharmacology of nicotinic drugs","volume":"96","author":"Henderson","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2026.117853_b0610","series-title":"Effects of Nicotine on Biological Systems II","first-page":"363","article-title":"Autoradiographic Distribution of Nicotinic Receptor Sites Labelled with [3H]Cytisine in the Human Brain","author":"Aubert","year":"1995"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0615","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/epi.13670","article-title":"Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Fisher","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2026.117853_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: An updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.117853_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106698","article-title":"Nicotinic acetylcholine receptors and epilepsy","volume":"189","author":"Becchetti","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0630","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng1095-201","article-title":"A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy","volume":"11","author":"Steinlein","year":"1995","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0635","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjp.0702154","article-title":"Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy","volume":"125","author":"Bertrand","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117853_b0640","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.phrs.2018.11.031","article-title":"Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry","volume":"139","author":"Indurthi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.117853_b0645","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2019.02.028","article-title":"Baicalein improves cognitive deficits and hippocampus impairments in temporal lobe epilepsy rats","volume":"1714","author":"Qian","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2026.117853_b0650","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.706225","article-title":"Cytisine Exerts an Anti-Epileptic Effect via \u03b17nAChRs in a Rat Model of Temporal Lobe Epilepsy","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0655","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1734-1140(13)70978-2","article-title":"Cytisine inhibits the anticonvulsant activity of phenytoin and lamotrigine in mice","volume":"65","author":"Tutka","year":"2013","journal-title":"Pharmacol. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0660","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1152\/jn.2001.86.6.3043","article-title":"Nicotinic Acetylcholine Receptor \u03b17 and \u03b14\u03b22 Subtypes Differentially Control GABAergic Input to CA1 Neurons in Rat Hippocampus","volume":"86","author":"Alkondon","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bcp.2026.117853_b0665","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuroscience.2013.11.044","article-title":"Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the \u03b17 nicotinic acetylcholine receptor","volume":"258","author":"Morioka","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2026.117853_b0670","unstructured":"O. World Health, Depressive disorder (depression), WHO Fact Sheets (2025)."},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0675","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"9","author":"Collaborators","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bcp.2026.117853_b0680","series-title":"Depression in adults: treatment and management (NG222)","author":"H. National Institute for, E. Care","year":"2022"},{"key":"10.1016\/j.bcp.2026.117853_b0685","series-title":"World mental health report: Transforming mental health for all","author":"O. World Health","year":"2022"},{"issue":"12","key":"10.1016\/j.bcp.2026.117853_b0690","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2026.117853_b0695","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41380-018-0219-x","article-title":"Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics","volume":"24","author":"Dulawa","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.bcp.2026.117853_b0700","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2014.12.028","article-title":"Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states","volume":"96","author":"Picciotto","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0710","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12974-022-02577-w","article-title":"Correction to: Pharmacologic activation of cholinergic alpha7 nicotinic receptors mitigates depressive-like behavior in a mouse model of chronic stress","volume":"19","author":"Zhao","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.bcp.2026.117853_b0715","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1755-5949.2008.00054.x","article-title":"TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity","volume":"14","author":"Lippiello","year":"2008","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2026.117853_b0720","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0725","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bcp.2010.06.040","article-title":"86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization","volume":"80","author":"Marks","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0730","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4062\/biomolther.2015.113","article-title":"Cytisine, a Partial Agonist of \u03b14\u03b22 Nicotinic Acetylcholine Receptors, Reduced Unpredictable Chronic Mild Stress-Induced Depression-Like Behaviors","volume":"24","author":"Han","year":"2016","journal-title":"Biomol Ther (seoul)"},{"issue":"2","key":"10.1016\/j.bcp.2026.117853_b0735","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2012.03.088","article-title":"Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells","volume":"516","author":"Turcanu","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"15","key":"10.1016\/j.bcp.2026.117853_b0740","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1007\/s00213-014-3472-y","article-title":"The effects of lobeline on nicotine withdrawal-induced depression-like behavior in mice","volume":"231","author":"Roni","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0745","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2026.117853_b0750","series-title":"Ischemic Stroke, StatPearls","author":"Lui","year":"2025"},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0755","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/biom14030305","article-title":"Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones","volume":"14","author":"Salaudeen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.117853_b0760","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: identifying novel targets for neuroprotection","volume":"115","author":"Lai","year":"2014","journal-title":"Prog. Neurobiol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117853_b0765","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion-from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.bcp.2026.117853_b0770","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/1673-5374.228711","article-title":"Cerebral ischemia and neuroregeneration","volume":"13","author":"Lee","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bcp.2026.117853_b0775","first-page":"3445","article-title":"Animal models of ischemic stroke and their application in clinical research","volume":"9","author":"Fluri","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2026.117853_b0780","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7526-6_18","article-title":"An In Vitro Oxygen-Glucose Deprivation Model for Studying Ischemia-Reperfusion Injury of Neuronal Cells","volume":"1717","author":"Ryou","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2026.117853_b0785","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1161\/STROKEAHA.108.521898","article-title":"Differential roles of NMDA receptor subtypes in ischemic neuronal cell death and ischemic tolerance","volume":"39","author":"Chen","year":"2008","journal-title":"Stroke"},{"issue":"13","key":"10.1016\/j.bcp.2026.117853_b0790","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/j.1742-4658.2007.05890.x","article-title":"CREB and cAMP response element-mediated gene expression in the ischemic brain","volume":"274","author":"Kitagawa","year":"2007","journal-title":"FEBS J."},{"issue":"6","key":"10.1016\/j.bcp.2026.117853_b0795","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/aps.2009.37","article-title":"Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance","volume":"30","author":"Bencherif","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.bcp.2026.117853_b0800","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s11064-018-2572-1","article-title":"Neuroprotection of Cytisine Against Cerebral Ischemia-Reperfusion Injury in Mice by Regulating NR2B-ERK\/CREB Signal Pathway","volume":"43","author":"Zhao","year":"2018","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bcp.2026.117853_b0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176512","article-title":"Cytisine\u2013N-methylene-(5,7,4\u2019-trihydroxy)- isoflavone ameliorates ischemic stroke-induced brain injury in mouse by regulating the oxidative stress and BDNF-Trkb\/Akt pathway","volume":"974","author":"Li","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2026.117853_b0810","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1007\/s12035-020-02077-z","article-title":"Nicotine Rescues Depressive-like Behaviors via \u03b17-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice","volume":"57","author":"Moriguchi","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.117853_b0815","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.biochi.2023.10.011","article-title":"Anti-smoking drugs cytisine and varenicline reduce cardiac reperfusion injury in rat model of myocardial ischemia","volume":"216","author":"Shaykhutdinova","year":"2024","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bcp.2026.117853_b0820","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/21691401.2019.1699813","article-title":"Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways","volume":"48","author":"Xu","year":"2020","journal-title":"Artif. Cells Nanomed. Biotechnol."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2026.118284","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522600184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:24:04Z","timestamp":1786083844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522600184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":164,"alternative-id":["S000629522600184X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117853","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic potential of cytisine and its derivatives in disorders of the central nervous system","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117853"}}